The one saving grace is the proprietary goods here

The one saving grace is the proprietary goods here--if the trials are successful, someone, somewhere with deep pockets will want the goods. I am not a stock market pro but I have been in Pharma for a number of years now and know how things go in it. I also am very familiar with govt red tape. IMHO, no one goes through what BMSN have had to go through to get this far with what they have in the pipeline just to be wiped out by some hacks looking to profit from a great fleecing.

We are dealing with level 1 illness cures here, after all.

Just MHO.